No Data
No Data
Amphastar Pharmaceuticals | 10-Q: Quarterly report
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)
Earnings Call Summary | Amphastar Pharmaceuticals(AMPH.US) Q1 2024 Earnings Conference
The following is a summary of the Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript:Financial Performance:Amphastar reported a 23% year-over-year increase in net revenue to $171.
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call